Crystal structures of HIV-1 reverse transcriptase complexes with thiocarbamate non-nucleoside inhibitors

O-[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethyl] (4-chlorophenyl)thiocarbamate

GAG-POL POLYPROTEIN P66 SUBUNIT, RESIDUES 600-1156

GAG-POL POLYPROTEIN P51 SUBUNIT, RESIDUES 600-1027

PISPIETVPVKLKPGMDGPKVKQWPLTEEKIKALVEICTEMEKEGKISKIGPENPYNTPVFAIKKKDSTKWRKLVDFREL
NKRTQDFWEVQLGIPHPAGLKKKKSVTVLDVGDAYFSVPLDEDFRKYTAFTIPSINNETPGIRYQYNVLPQGWKGSPAIF
QSSMTKILEPFKKQNPDIVIYQYMDDLYVGSDLEIGQHRTKIEELRQHLLRWGLTTPDKKHQKEPPFLWMGYELHPDKWT
VQPIVLPEKDSWTVNDIQKLVGKLNWASQIYPGIKVRQLCKLLRGTKALTEVIPLTEEAELELAENREILKEPVHGVYYD
PSKDLIAEIQKQGQGQWTYQIYQEPFKNLKTGKYARMRGAHTNDVKQLTEAVQKITTESIVIWGKTPKFKLPIQKETWET
WWTEYWQATWIPEWEFVNTPPLVKLWYQLEKEPIVGAETFYVDGAANRETKLGKAGYVTNKGRQKVVPLTNTTNQKTELQ
AIYLALQDSGLEVNIVTDSQYALGIIQAQPDKSESELVNQIIEQLIKKEKVYLAWVPAHKGIGGNEQVDKLVSAGIR

PISPIETVPVKLKPGMDGPKVKQWPLTEEKIKALVEICTEMEKEGKISKIGPENPYNTPVFAIKKKDSTKWRKLVDFREL
NKRTQDFWEVQLGIPHPAGLKKKKSVTVLDVGDAYFSVPLDEDFRKYTAFTIPSINNETPGIRYQYNVLPQGWKGSPAIF
QSSMTKILEPFKKQNPDIVIYQYMDDLYVGSDLEIGQHRTKIEELRQHLLRWGLTTPDKKHQKEPPFLWMGYELHPDKWT
VQPIVLPEKDSWTVNDIQKLVGKLNWASQIYPGIKVRQLCKLLRGTKALTEVIPLTEEAELELAENREILKEPVHGVYYD
PSKDLIAEIQKQGQGQWTYQIYQEPFKNLKTGKYARMRGAHTNDVKQLTEAVQKITTESIVIWGKTPKFKLPIQKETWET
WWTEYWQATWIPEWEFVNTPPLVKLWYQ

HIV-1 PROTEASE IN COMPLEX WITH THE CYCLIC SULFAMIDE INHIBITOR AHA006

HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR MSL370

CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE COVALENTLYTETHERED TO DNA TEMPLATE -PRIMER SOLVED TO 2.8 ANGSTROMS

CRYSTAL STRUCTURE OF 3TC-RESISTANT M184I MUTANT OF HIV-1 REVERSE TRANSCRIPTASE

HIV-1 PROTEASE IN COMPLEX WITH THE CYCLIC UREA INHIBITOR AHA001

STRUCTURAL AND KINETIC ANALYSIS OF DRUG RESISTANT MUTANTS OF HIV-1 PROTEASE

CRYSTAL STRUCTURE OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R100943

K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITHEFIVARENZ

HIV-1 PROTEASE IN COMPLEX WITH FLUORO SUBSTITUTED DIOL-BASED C2-SYMMETRIC INHIBITOR

CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) INCOMPLEX WITH JANSSEN- R147681

WILD TYPE HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITHEFAVIRENZ

HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA409

HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA403

HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO TEMPLATE-PRIMERWITH TENOFOVIR-DIPHOSPHATE BOUND AS THE INCOMINGNUCLEOTIDE SUBSTRATE

REVERSE TRANSCRIPTASE NON-NUCLEOSIDE BINDING SITE COMPLEXED WITH TIBO (THEORETICAL MODEL)

HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA425

HIV-1 MUTANT (V82F, I84V) PROTEASE COMPLEXED WITH DMP323

CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) INCOMPLEX WITH R221239

CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) INCOMPLEX WITH JANSSEN- R120394.

HIV-1 REVERSE TRANSCRIPTASE (HIV-1 RT) MUTANT WITH CYS 280 REPLACED BY SER (C280S )

REVERSE TRANSCRIPTASE NON-NUCLEOSIDE BINDING SITE COMPLEXED WITH IMIDAZODIPYRIDODIAZEPINE (UK -129,485) (THEORETICAL MODEL)

K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITHTHE INHIBITOR PNU142721

HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH THE INHIBITORMSC194

C-TERMINAL DNA-BINDING DOMAIN OF HIV-1 INTEGRASE, NMR, 42 STRUCTURES

HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO PRE-TRANSLOCATION AZTMP-TERMINATED DNA ( COMPLEX N)

REVERSE TRANSCRIPTASE NON-NUCLEOSIDE BINDING SITE COMPLEXED WITH PHENYL-ISOINDOLINONE ( THEORETICAL MODEL)

HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA435

STRUCTURE OF A CATALYTIC COMPLEX OF HIV-1 REVERSE TRANSCRIPTASE: IMPLICATIONS FOR NUCLEOSIDE ANALOG DRUG RESISTANCE

HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA428

HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH A DOUBLE-STRANDED DEOXYRIBONUCLEIC ACID AND FAB28

TWO-CARBON-ELONGATED HIV-1 PROTEASE INHIBITORS WITH A TERTIARY-ALCOHOL-CONTAINING TRANSITION-STATE MIMIC

CRYSTAL STRUCTURE OF K103N MUTANT HIV-1 REVERSETRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R165335

CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) INCOMPLEX WITH JANSSEN- R129385

HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO POST-TRANSLOCATION AZTMP-TERMINATED DNA ( COMPLEX P)

HIV-1 PROTEASE COMPLEXED WITH SKF 107457 ( HEG)

REVERSE TRANSCRIPTASE NON-NUCLEOSIDE BINDING SITE COMPLEXED WITH THIAZOLOISOINDOLINONE ( THEORETICAL MODEL)

REVERSE TRANSCRIPTASE NON-NUCLEOSIDE BINDING SITE COMPLEXED WITH ALPHA-APA (R89439) ( THEORETICAL MODEL)

HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH THE INHIBITOR MSC204

CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) INCOMPLEX WITH THR-50

HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE COMPLEXED WITH A 33-BASE NUCLEOTIDE RIBONUCLEIC ACID PSEUDOKNOT

HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA322

CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) INCOMPLEX WITH JANSSEN- R157208

HIV-1 REVERSE TRANSCRIPTASE (RIBONUCLEASE H DOMAIN)

HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA369

CRYSTAL STRUCTURE OF MET184ILE MUTANT OF HIV -1 REVERSETRANSCRIPTASE IN COMPLEX WITH DOUBLE STRANDED DNA TEMPLATE-PRIMER

HIV-1 PROTEASE COMPLEX WITH SUBSTRATE ( THEORETICAL MODEL)

REVERSE TRANSCRIPTASE NON-NUCLEOSIDE BINDING SITE COMPLEXED WITH NEVIRAPINE (THEORETICAL MODEL)

HIV-1 MUTANT (I84V) PROTEASE COMPLEXED WITH DMP323

HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR MSA367

HIV-1 PROTEASE COMPLEXED WITH INHIBITOR CGP 53820

HIV-1 PROTEASE COMPLEXED WITH SKF 108738 ( HEF)

HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE (HIV-1RT) MUTANT WITH CYS 280 REPLACED BY SER (C280S)

HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH CP-94,707

CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) INCOMPLEX WITH JANSSEN- R165481

HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA388

CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEXWITH A POLYPURINE TRACT RNA:DNA

HIV-1 MUTANT (V82F) PROTEASE COMPLEXED WITH DMP323

HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO TENOFOVIRTERMINATED TEMPLATE-PRIMER (COMPLEX P)

ACTIVE-SITE MOBILITY IN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 PROTEASE AS DEMONSTRATED BY CRYSTAL STRUCTURE OF A28S MUTANT

HIV-1 MUTANT (I84V) PROTEASE COMPLEXED WITH DMP450

STRUCTURAL STUDIES OF HIV AND FIV PROTEASES COMPLEXED WITHAN EFFICIENT INHIBITOR OF FIV PR

HIV-1 PROTEASE COMPLEXED WITH THE INHIBITOR SB203386

HIV-1 PROTEASE COMPLEXED WITH THE INHIBITOR A76928 (S,S)

CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) INCOMPLEX WITH JANSSEN- R185545

REVERSE TRANSCRIPTASE NON-NUCLEOSIDE BINDING SITE COMPLEXED WITH HEPT (THEORETICAL MODEL)

RIBONUCLEASE H DOMAIN OF HIV-1 REVERSE TRANSCRIPTASE

CRYSTAL STRUCTURES OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXES WITH THIOCARBAMATE NON- NUCLEOSIDE INHIBITORS

SHEET
THE SHEET STRUCTURE OF THIS MOLECULE IS BIFURCATED. IN
ORDER TO REPRESENT THIS FEATURE IN THE SHEET RECORDS BELOW,
TWO SHEETS ARE DEFINED.

HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS.

DNA-DIRECTED DNA POLYMERASE, THIOCARBAMATES, PHOSPHORYLATION, DNA INTEGRATION, MAGNESIUM, ZINC-FINGER, RNA-BINDING, TRANSFERASE, LIPOPROTEIN, CORE PROTEIN, ENDONUCLEASE, METAL-BINDING, ZINC, AIDS, HIV-1, VIRION, NUCLEUS, MEMBRANE, ASPARTYL PROTEASE, CAPSID MATURATION, MULTIFUNCTIONAL ENZYME, RNA-DIRECTED DNA POLYMERASE, REVERSE TRANSCRIPTASE, NUCLEOTIDYLTRANSFERASE, DNA RECOMBINATION, VIRAL NUCLEOPROTEIN, PROTEASE, NUCLEASE, MYRISTATE, HYDROLASE, CYTOPLASM, NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS